An intelligent synthetic biomarker-based theranostic nanoplatform for ultrasensitive microtumor detection via noninvasive urinary analysis

Key Points

• Ultrasensitive detection of microtumors was achieved using a novel synthetic biomarker.
• The analysis reported precision at detecting microtumors in urinary samples with high accuracy.
• Evidence was gathered through a noninvasive urinary analysis method, facilitating early diagnostics.
• The implications of this theranostic platform highlight the potential for noninvasive cancer detection, improving patient management.